BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Direct-acting antivirals
1
Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
8/7/2019 7:09:17 AM | Browse: 98 | Download: 97
2
Leukocytoclastic vasculitis caused by hepatitis C virus in a liver transplant recipient: A case report
4/26/2019 3:40:00 AM | Browse: 131 | Download: 120
3
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients
10/27/2018 4:40:10 AM | Browse: 195 | Download: 147
4
Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus
10/12/2018 5:32:21 AM | Browse: 129 | Download: 83
5
Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
9/27/2018 9:38:46 AM | Browse: 230 | Download: 136
6
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 286 | Download: 153
7
Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience
1/26/2018 8:09:36 AM | Browse: 234 | Download: 155
8
Impact of sustained virologic response on chronic kidney disease progression in hepatitis C
12/27/2017 10:31:19 AM | Browse: 313 | Download: 184
9
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
12/5/2017 1:55:00 AM | Browse: 249 | Download: 194
10
Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
8/28/2017 6:54:48 AM | Browse: 482 | Download: 504
11
Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
6/26/2017 10:23:05 AM | Browse: 337 | Download: 226
12
Is it enough to eliminate hepatitis C virus to reverse the damage caused by the infection?
2/24/2017 9:02:00 AM | Browse: 346 | Download: 354
13
Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
7/29/2016 8:32:00 PM | Browse: 453 | Download: 599
14
Hepatitis C virus genotypes in Myanmar
7/15/2016 3:38:00 PM | Browse: 425 | Download: 529
15
Antiviral therapy for hepatitis C: Has anything changed for pregnant/lactating women?
4/19/2016 2:32:00 PM | Browse: 539 | Download: 346
16
Update on hepatitis C: Direct-acting antivirals
12/4/2015 3:24:00 PM | Browse: 480 | Download: 787
17
Hepatitis C virus: A global view
11/18/2015 11:12:00 AM | Browse: 629 | Download: 600
18
Hepatitis C virus infection: Are there still specific problems with genotype 3?
11/11/2015 1:33:00 PM | Browse: 582 | Download: 779
19
Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes
10/14/2015 12:06:00 PM | Browse: 424 | Download: 708
20
Psychosocial assessment and monitoring in the new era of non-interferon-alpha hepatitis C virus treatments
9/9/2015 2:44:00 PM | Browse: 464 | Download: 690
21
New treatment strategies for hepatitis C infection
8/21/2015 1:38:00 PM | Browse: 580 | Download: 724
22
Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade
4/19/2015 5:46:00 PM | Browse: 646 | Download: 644
23
Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control
3/30/2015 5:46:00 PM | Browse: 542 | Download: 700
24
Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6
3/13/2015 3:29:00 PM | Browse: 532 | Download: 618
25
Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy
8/25/2014 2:47:00 PM | Browse: 373 | Download: 241